CAH stock icon

Cardinal Health
CAH

$95.97
0.59%

Market Cap: 23.4B

 

About: Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Employees: 48,000

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 9 analysts
0
News positive %
of 10 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

74% more call options, than puts

Call options by funds: $287M | Put options by funds: $165M

12% more capital invested

Capital invested by funds: $21.3B [Q4 2023] → $23.9B (+$2.55B) [Q1 2024]

2.07% more ownership

Funds ownership: 85.99% [Q4 2023] → 88.06% (+2.07%) [Q1 2024]

7% more first-time investments, than exits

New positions opened: 105 | Existing positions closed: 98

1% more funds holding

Funds holding: 1,010 [Q4 2023] → 1,017 (+7) [Q1 2024]

7% less repeat investments, than reductions

Existing positions increased: 363 | Existing positions reduced: 391

25% less funds holding in top 10

Funds holding in top 10: 16 [Q4 2023] → 12 (-4) [Q1 2024]

Research analyst outlook

9 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$94
2%
downside
Avg. target
$118
23%
upside
High target
$130
35%
upside

9 analyst ratings

positive
67%
neutral
22%
negative
11%
Evercore ISI Group
Elizabeth Anderson
9%upside
$105
In-Line
Maintained
9 Jul 2024
Baird
Eric Coldwell
35%upside
$130
Outperform
Maintained
9 Jul 2024
Argus Research
David Toung
20%upside
$115
Buy
Maintained
15 May 2024
Evercore ISI Group
Elizabeth Anderson
20%upside
$115
In-Line
Maintained
3 May 2024
Baird
Eric Coldwell
33%upside
$128
Outperform
Maintained
3 May 2024

Financial journalist opinion

Based on 10 articles about CAH published over the past 30 days